Ullman Anders 4
4 · Verona Pharma plc · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Ullman Anders
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-08-01−24,000→ 72,000 total→ Ordinary Shares (24,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-08-01+24,000→ 358,856 total
Footnotes (4)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]Consists of 358,856 Ordinary Shares represented by 44,857 ADSs.
- [F3]Represents an award of Restricted Share Units ("RSUs") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
- [F4]The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.